Transcriptional activation of the human insulin receptor gene by 1,25-dihydroxyvitamin D(3)

Cell Biochem Funct. 2002 Sep;20(3):227-32. doi: 10.1002/cbf.951.

Abstract

Treatment with 10(-8) M 1,25-dihydroxyvitamin D(3) for 24 h causes transcriptional activation of the human insulin receptor gene in U-937 human promonocytic cells. The activation seems to potentiate the response to insulin in terms of glucose oxidation. Wortmannin, a phosphatidylinositol 3-kinase inhibitor, causes a greater inhibition of insulin-stimulated glucose oxidation in 1,25-dihydroxyvitamin D(3)-treated cells than in untreated cells. This suggests a stimulation of phosphatidylinositol 3-kinase activity by 1,25-dihydroxyvitamin D(3), which could mediate, at least in part, the potentiation of the insulin response.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Androstadienes / pharmacology
  • Calcitriol / pharmacology*
  • Calcium Channel Agonists / pharmacology*
  • Cell Line
  • Dose-Response Relationship, Drug
  • Enzyme Inhibitors / pharmacology
  • Glucose / metabolism
  • Humans
  • Insulin / metabolism
  • Luciferases / metabolism
  • Oxygen / metabolism
  • Plasmids / metabolism
  • Receptor, Insulin / genetics*
  • Receptor, Insulin / metabolism*
  • Transcriptional Activation*
  • Transfection
  • U937 Cells
  • Wortmannin

Substances

  • Androstadienes
  • Calcium Channel Agonists
  • Enzyme Inhibitors
  • Insulin
  • Luciferases
  • Receptor, Insulin
  • Calcitriol
  • Glucose
  • Oxygen
  • Wortmannin